{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:14:12Z","timestamp":1790399652989,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05832-1","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:38:52Z","timestamp":1741271932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Fecal microbiota transplantation restores gut microbiota diversity in children with active Crohn\u2019s disease: a prospective trial"],"prefix":"10.1186","volume":"23","clinical-trial-number":[{"clinical-trial-number":"nct05321758","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05321745","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Biao","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongling","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengling","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6071-9656","authenticated-orcid":false,"given":"Sainan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"5832_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017. https:\/\/doi.org\/10.1016\/S0140-6736(17)32448-0.","journal-title":"Lancet"},{"key":"5832_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa037","author":"SE Roberts","year":"2020","unstructured":"Roberts SE, Thorne K, Thapar N, et al. A systematic review and meta-analysis of paediatric inflammatory bowel disease incidence and prevalence across Europe. J Crohns Colitis. 2020. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa037.","journal-title":"J Crohns Colitis"},{"key":"5832_CR3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.282","author":"ME Kuenzig","year":"2022","unstructured":"Kuenzig ME, Fung SG, Marderfeld L, et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review. Gastroenterology. 2022. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.282.","journal-title":"Gastroenterology"},{"key":"5832_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.03.002","author":"DY Jeong","year":"2019","unstructured":"Jeong DY, Kim S, Son MJ, et al. Induction and maintenance treatment of inflammatory bowel disease: a comprehensive review. Autoimmun Rev. 2019. https:\/\/doi.org\/10.1016\/j.autrev.2019.03.002.","journal-title":"Autoimmun Rev"},{"key":"5832_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00154-1","author":"TL Parigi","year":"2023","unstructured":"Parigi TL, D\u2019Amico F, Abreu MT, et al. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. Lancet Gastroenterol Hepatol. 2023. https:\/\/doi.org\/10.1016\/S2468-1253(23)00154-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5832_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105075","author":"F Magro","year":"2020","unstructured":"Magro F, Cordeiro G, Dias AM, Estevinho MM. Inflammatory bowel disease\u2014non-biological treatment. Pharmacol Res. 2020. https:\/\/doi.org\/10.1016\/j.phrs.2020.105075.","journal-title":"Pharmacol Res"},{"key":"5832_CR7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.294","author":"R Pittayanon","year":"2020","unstructured":"Pittayanon R, Lau JT, Leontiadis GI, et al. Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review. Gastroenterology. 2020. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.294.","journal-title":"Gastroenterology"},{"key":"5832_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.10.005","author":"A Brusaferro","year":"2019","unstructured":"Brusaferro A, Cavalli E, Farinelli E, Cozzali R, Principi N, Esposito S. Gut dysbiosis and paediatric Crohn\u2019s disease. J Infect. 2019. https:\/\/doi.org\/10.1016\/j.jinf.2018.10.005.","journal-title":"J Infect"},{"key":"5832_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-0792-5","author":"H Sokol","year":"2020","unstructured":"Sokol H, Landman C, Seksik P, et al. Fecal microbiota transplantation to maintain remission in Crohn\u2019s disease: a pilot randomized controlled study. Microbiome. 2020. https:\/\/doi.org\/10.1186\/s40168-020-0792-5.","journal-title":"Microbiome"},{"key":"5832_CR10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-111717-122956","author":"RE Ooijevaar","year":"2019","unstructured":"Ooijevaar RE, Terveer EM, Verspaget HW, Kuijper EJ, Keller JJ. Clinical application and potential of fecal microbiota transplantation. Annu Rev Med. 2019. https:\/\/doi.org\/10.1146\/annurev-med-111717-122956.","journal-title":"Annu Rev Med"},{"key":"5832_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329948","author":"LR Lopetuso","year":"2023","unstructured":"Lopetuso LR, Deleu S, Godny L, et al. The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut. 2023. https:\/\/doi.org\/10.1136\/gutjnl-2023-329948.","journal-title":"Gut"},{"key":"5832_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103036","author":"S Porcari","year":"2023","unstructured":"Porcari S, Baunwall SMD, Occhionero AS, et al. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis. J Autoimmun. 2023. https:\/\/doi.org\/10.1016\/j.jaut.2023.103036.","journal-title":"J Autoimmun"},{"key":"5832_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2023.03.020","author":"S Porcari","year":"2023","unstructured":"Porcari S, Benech N, Valles-Colomer M, et al. Key determinants of success in fecal microbiota transplantation: from microbiome to clinic. Cell Host Microbe. 2023. https:\/\/doi.org\/10.1016\/j.chom.2023.03.020.","journal-title":"Cell Host Microbe"},{"key":"5832_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1083236","author":"B Zou","year":"2023","unstructured":"Zou B, Liu S, Li X, et al. Repeated and multiple fecal microbiota transplantations plus partial enteral nutrition as the first-line treatment in active pediatric Crohn\u2019s disease. Front Cell Infect Microbiol. 2023. https:\/\/doi.org\/10.3389\/fcimb.2023.1083236.","journal-title":"Front Cell Infect Microbiol"},{"key":"5832_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.6","author":"C Staley","year":"2017","unstructured":"Staley C, Hamilton MJ, Vaughn BP, et al. Successful resolution of recurrent clostridium difficile infection using freeze-dried, encapsulated fecal microbiota; pragmatic cohort study. Am J Gastroenterol. 2017. https:\/\/doi.org\/10.1038\/ajg.2017.6.","journal-title":"Am J Gastroenterol"},{"key":"5832_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17077","author":"D Kao","year":"2017","unstructured":"Kao D, Roach B, Silva M, et al. Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent clostridium difficile infection: a randomized clinical trial. JAMA. 2017. https:\/\/doi.org\/10.1001\/jama.2017.17077.","journal-title":"JAMA"},{"key":"5832_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz151","author":"B Verstockt","year":"2020","unstructured":"Verstockt B, Mertens E, Dreesen E, et al. Influence of drug exposure on vedolizumab-induced endoscopic remission in anti-tumour necrosis factor [TNF] naive and anti-TNF exposed IBD patients. J Crohns Colitis. 2020. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz151.","journal-title":"J Crohns Colitis"},{"key":"5832_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.04.012","author":"MA Cozijnsen","year":"2020","unstructured":"Cozijnsen MA, Ben Shoham A, Kang B, et al. Development and validation of the mucosal inflammation noninvasive index for pediatric Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.012.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5832_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001495","author":"C Du","year":"2021","unstructured":"Du C, Luo Y, Walsh S, Grinspan A. Oral fecal microbiota transplant capsules are safe and effective for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. J Clin Gastroenterol. 2021. https:\/\/doi.org\/10.1097\/MCG.0000000000001495.","journal-title":"J Clin Gastroenterol"},{"key":"5832_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu135","author":"I Youngster","year":"2014","unstructured":"Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014. https:\/\/doi.org\/10.1093\/cid\/ciu135.","journal-title":"Clin Infect Dis"},{"key":"5832_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00400-3","author":"C Haifer","year":"2022","unstructured":"Haifer C, Paramsothy S, Kaakoush NO, et al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022. https:\/\/doi.org\/10.1016\/S2468-1253(21)00400-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5832_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16148","author":"C Marcella","year":"2021","unstructured":"Marcella C, Cui B, Kelly CR, Ianiro G, Cammarota G, Zhang F. Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Aliment Pharmacol Ther. 2021. https:\/\/doi.org\/10.1111\/apt.16148.","journal-title":"Aliment Pharmacol Ther"},{"key":"5832_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030548","author":"RE Ooijevaar","year":"2021","unstructured":"Ooijevaar RE, van Nood E, Goorhuis A, et al. Ten-year follow-up of patients treated with fecal microbiota transplantation for recurrent Clostridioides difficile infection from a randomized controlled trial and review of the literature. Microorganisms. 2021. https:\/\/doi.org\/10.3390\/microorganisms9030548.","journal-title":"Microorganisms"},{"key":"5832_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.09.001","author":"YK Yau","year":"2024","unstructured":"Yau YK, Lau LHS, Lui RNS, et al. Long-term safety outcomes of fecal microbiota transplantation: real-world data over 8 years from the Hong Kong FMT registry. Clin Gastroenterol Hepatol. 2024. https:\/\/doi.org\/10.1016\/j.cgh.2023.09.001.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5832_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.964154","author":"B Zou","year":"2022","unstructured":"Zou B, Liu SX, Li XS, et al. Long-term safety and efficacy of fecal microbiota transplantation in 74 children: a single-center retrospective study. Front Pediatr. 2022. https:\/\/doi.org\/10.3389\/fped.2022.964154.","journal-title":"Front Pediatr"},{"key":"5832_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103062","author":"R Wu","year":"2023","unstructured":"Wu R, Xiong R, Li Y, Chen J, Yan R. Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation. J Autoimmun. 2023. https:\/\/doi.org\/10.1016\/j.jaut.2023.103062.","journal-title":"J Autoimmun"},{"key":"5832_CR27","doi-asserted-by":"publisher","first-page":"615056","DOI":"10.3389\/fimmu.2020.615056","volume":"11","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Ling Z, Li L. The intestinal microbiota and colorectal cancer. Front Immunol. 2020;11:615056. https:\/\/doi.org\/10.3389\/fimmu.2020.615056.","journal-title":"Front Immunol"},{"issue":"1","key":"5832_CR28","doi-asserted-by":"publisher","first-page":"2149019","DOI":"10.1080\/19490976.2022.2149019","volume":"14","author":"B Kircher","year":"2022","unstructured":"Kircher B, Woltemate S, Gutzki F, Schl\u00fcter D, Geffers R, B\u00e4hre H, Vital M. Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data. Gut Microbes. 2022;14(1):2149019. https:\/\/doi.org\/10.1080\/19490976.2022.2149019.","journal-title":"Gut Microbes"},{"issue":"1","key":"5832_CR29","doi-asserted-by":"publisher","first-page":"2035659","DOI":"10.1080\/19490976.2022.2035659","volume":"14","author":"K Ka\u017amierczak-Siedlecka","year":"2022","unstructured":"Ka\u017amierczak-Siedlecka K, Skonieczna-\u017bydecka K, Hupp T, Duchnowska R, Marek-Trzonkowska N, Po\u0142om K. Next-generation probiotics\u2014do they open new therapeutic strategies for cancer patients? Gut Microbes. 2022;14(1):2035659. https:\/\/doi.org\/10.1080\/19490976.2022.2035659.","journal-title":"Gut Microbes"},{"issue":"1","key":"5832_CR30","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1038\/s41467-024-47594-w","volume":"15","author":"SM Holmberg","year":"2024","unstructured":"Holmberg SM, Feeney RH, Prasoodanan PKV, Pu\u00e9rtolas-Balint F, Singh DK, Wongkuna S, Zandbergen L, Hauner H, Brandl B, Nieminen AI, Skurk T, Schroeder BO. The gut commensal Blautia maintains colonic mucus function under low-fiber consumption through secretion of short-chain fatty acids. Nat Commun. 2024;15(1):3502. https:\/\/doi.org\/10.1038\/s41467-024-47594-w.","journal-title":"Nat Commun"},{"key":"5832_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051234","author":"C Amoroso","year":"2020","unstructured":"Amoroso C, Perillo F, Strati F, et al. The role of gut microbiota biomodulators on mucosal immunity and intestinal inflammation. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9051234.","journal-title":"Cells"},{"key":"5832_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07359-8","author":"C Burrello","year":"2018","unstructured":"Burrello C, Garavaglia F, Cribi\u00f9 FM, et al. Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-07359-8.","journal-title":"Nat Commun"},{"key":"5832_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3503","author":"G Falony","year":"2016","unstructured":"Falony G, Joossens M, Vieira-Silva S, et al. Population-level analysis of gut microbiome variation. Science. 2016. https:\/\/doi.org\/10.1126\/science.aad3503.","journal-title":"Science"},{"key":"5832_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.13629","author":"H Mulhall","year":"2022","unstructured":"Mulhall H, DiChiara JM, Huck O, Amar S. Pasteurized Akkermansia muciniphila reduces periodontal and systemic inflammation induced by Porphyromonas gingivalis in lean and obese mice. J Clin Periodontol. 2022. https:\/\/doi.org\/10.1111\/jcpe.13629.","journal-title":"J Clin Periodontol"},{"issue":"5","key":"5832_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s13238-020-00745-3","volume":"12","author":"S Liu","year":"2021","unstructured":"Liu S, Zhao W, Lan P, Mou X. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein Cell. 2021;12(5):331\u201345. https:\/\/doi.org\/10.1007\/s13238-020-00745-3.","journal-title":"Protein Cell"},{"issue":"10","key":"5832_CR36","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/ueg2.12338","volume":"10","author":"J Zheng","year":"2022","unstructured":"Zheng J, Sun Q, Zhang J, Ng SC. The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis. United Eur Gastroenterol J. 2022;10(10):1091\u2013102. https:\/\/doi.org\/10.1002\/ueg2.12338.","journal-title":"United Eur Gastroenterol J"},{"issue":"7","key":"5832_CR37","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.cgh.2024.01.026","volume":"22","author":"R Atreya","year":"2024","unstructured":"Atreya R, Neurath MF. Biomarkers for personalizing IBD therapy: the quest continues. Clin Gastroenterol Hepatol. 2024;22(7):1353\u201364. https:\/\/doi.org\/10.1016\/j.cgh.2024.01.026.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05832-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05832-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05832-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:38:57Z","timestamp":1741271937000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05832-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5832"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05832-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (TJ-IRB20220127). Written informed consent has been obtained from the patients to publish this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}